Quantcast

Latest Vaccination Stories

2014-05-30 12:26:02

MERIDEN, Conn., May 30, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that Astellas Pharma has submitted an application for marketing approval of recombinant influenza HA vaccine ASP7374 (marketed as Flublok® in the United States by Protein Sciences) to the Ministry of Health, Labour and Welfare in Japan for the prevention of influenza. UMN Pharma, which is partnered with Astellas, holds an exclusive license from Protein Sciences for the development and marketing...

2014-05-30 04:22:21

BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014. The common stock will continue to trade under the symbol "INO." As filed on May 22, 2014, the Company's stockholders approved the proposal of a reverse...

2014-05-29 16:26:48

WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- The PATH Malaria Vaccine Initiative (MVI) announced today that C. Richter (Rick) King, PhD, has been named Director of Research & Development (R&D). MVI drives the development of safe and effective vaccines to combat malaria. Malaria still kills more than 600,000 people worldwide, and half the world's population remains at risk of contracting the disease. Dr. King is an accomplished scientist with more than 25 years of...

2014-05-29 12:28:35

ANNAPOLIS, Md., May 29, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that new analytical data from the Company's SparVax(®) anthrax vaccine program were presented at the 114(th) General Meeting of the American Society for Microbiology (ASM), held recently in Boston, Massachusetts. In a poster presentation entitled "Evidence Correlating Changes in Structure and Biological Activity for a Recombinant Protective Antigen (rPA) Anthrax Vaccine," Dr. Bradford Powell,...

2014-05-27 23:10:19

“Only 24% of (Hispanic male) participants believed that the HPV vaccine could prevent future problems, and 53% said they would not be vaccinate,” according to the Journal of Transcultural Nursing from May 19, 2014 (1). polyDNA reviews the study and recommends Gene-Eden-VIR and Novirin to help the immune systems target the latent human papillomavirus. Rochester, NY (PRWEB) May 27, 2014 A new study reported the attitudes of Hispanic men regarding HPV vaccination. Researchers learned...

2014-05-27 11:33:01

Canadian Medical Association Journal Employers planning to implement mandatory influenza vaccination policies for health care workers need to understand the implications, according to an analysis published in CMAJ (Canadian Medical Association Journal). Vaccination rates among health care workers are less than 50%, well below the level necessary for herd immunity. Evidence indicates that vaccination of health care workers can benefit patient health, leading to a move by many to...

Ebola Vaccine Is Safe And Can Produce Strong Immune Response In Chimpanzees: Study
2014-05-27 03:16:32

University of Cambridge The first conservation-specific vaccine trial on captive chimpanzees has proved a vaccine against Ebola virus is both safe and capable of producing a robust immune response in chimpanzees. This unprecedented study, published in the journal PNAS, shows that 'orphan' vaccines - which never complete the expensive licensing process for human use - can be co-opted for use on wildlife and might be a godsend for highly endangered species such as gorillas and...

2014-05-27 04:21:46

BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its 90%-owned subsidiary, VGX Animal Health, Inc. (VAH), has concluded an agreement for the sale of its animal health assets to Plumbline Life Sciences, Inc. (PLS) of Korea. The assets being transferred include an exclusive license with Inovio for animal applications of its growth hormone-releasing hormone (GHRH) technology and animal DNA vaccines plus a non-exclusive license...

Parasite-Blocking Antigen Discovery May Lead To Malaria Vaccine
2014-05-23 08:37:58

[ Watch the Video: Protein May Lead To Malaria Vaccine ] Lawrence LeBlond for redOrbit.com - Your Universe Online Malaria remains a dangerous disease in the developing world, killing more than 627,000 people a year, according to the World Health Organization (WHO). Because most deaths associated with malaria occur in children in Sub-Saharan Africa, finding a vaccine against the deadly virus is all too important. New research, by a team from Rhode Island Hospital (RIH), has uncovered...

2014-05-23 04:20:51

BLUE BELL, Pa., May 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock. The Company's Board of Directors subsequently approved the immediate implementation of a 1-for-4 reverse stock split of Inovio's common stock, where each 4 shares of issued and outstanding common stock and equivalents...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related